Skip to main content
SpringerLink
Log in

Infectious Gastroenteritis and Colitis

  • Chapter
  • First Online:
Diarrhea

Part of the book series: Clinical Gastroenterology ((CG))

Summary

In this chapter, we discuss the epidemiology, etiology, presentation, diagnosis, and treatment of infectious diarrhea in immunocompetent persons. The features of small intestinal and ileocolonic disease as related to possible causative agents are presented. Additionally, there is an emphasis on specific pathogens, with a comprehensive review of viral, bacterial, and parasitic causes of diarrhea. We then discuss the intricacies of the clinical and diagnostic evaluation, as well as treatment. Specifically, we evaluate the severity of illness, historical clues to etiology, the appropriateness of diagnostic testing in various clinical situations, and which diagnostic tests are clinically relevant. Rehydration therapy is discussed along with nutrition and electrolyte support. The appropriate use of antidiarrheal and antimicrobial medications is reviewed, along with a brief discussion of empiric therapy and the individual and public health consequences associated with infection and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bern C. Diarrhoeal diseases. In: Murray CJL, Lopez AD, Mathers CD, eds. The global epidemiology of infectious diseases. Geneva, Switzerland: World Health Organization; 2004.

    Google Scholar 

  2. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bulletin of the World Health Organization 2003;81(3):197–204.

    PubMed  Google Scholar 

  3. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32(3):331–351.

    Article  PubMed  CAS  Google Scholar 

  4. Jones TF, Bulens SN, Gettner S, et al. Use of stool collection kits delivered to patients can improve confirmation of etiology in foodborne disease outbreaks. Clin Infect Dis 2004;39(10):1454–1459.

    Article  PubMed  Google Scholar 

  5. Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996; 22(6):1019–1025.

    Article  PubMed  CAS  Google Scholar 

  6. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med 2004 Jan 1;350(1):38–47.

    Article  PubMed  CAS  Google Scholar 

  7. Wilhelmi I, Roman E, Sanchez-Fauquier A. Viruses causing gastroenteritis. Clin Microbiol Infect 2003;9(4):247–262.

    Article  PubMed  CAS  Google Scholar 

  8. Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004;17(5):461–469.

    Article  PubMed  Google Scholar 

  9. Lorrot M, Vasseur M. How do the rotavirus NSP4 and bacterial enterotoxins lead differently to diarrhea? Virol J 2007;4:31.

    Article  PubMed  Google Scholar 

  10. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58(RR-2):1–25.

    PubMed  Google Scholar 

  11. Flores J, Okhuysen PC. Enteroaggregative Escherichia coli infection. Curr Opin Gastroenterol 2009;25(1):8–11.

    Article  PubMed  Google Scholar 

  12. Adachi JA, Jiang ZD, Mathewson JJ, et al. Enteroaggregative Escherichia coli as a major etiologic agent in traveler’s diarrhea in 3 regions of the world. Clin Infect Dis 2001;32(12):1706–1709.

    Article  PubMed  CAS  Google Scholar 

  13. DuPont HL. Clinical practice. Bacterial diarrhea. N Engl J Med 2009; 361(16):1560–1569.

    Article  PubMed  CAS  Google Scholar 

  14. Spano LC, Sadovsky AD, Segui PN, et al. Age-specific prevalence of diffusely adherent Escherichia coli in Brazilian children with acute diarrhoea. J Med Microbiol 2008;57(Pt 3):359–363.

    Article  PubMed  Google Scholar 

  15. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004;363(9404): 223–233.

    Article  PubMed  CAS  Google Scholar 

  16. King AA, Ionides EL, Pascual M, Bouma MJ. Inapparent infections and cholera dynamics. Nature 2008;454(7206):877–880.

    Article  PubMed  CAS  Google Scholar 

  17. von Seidlein L, Wang XY, Macuamule A, et al. Is HIV infection associated with an increased risk for cholera? Findings from a case–control study in Mozambique. Trop Med Int Health 2008;13(5):683–688.

    Article  Google Scholar 

  18. Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev 2009(2):CD006519.

    Google Scholar 

  19. Raghupathy P, Ramakrishna BS, Oommen SP, et al. Amylase-resistant starch as adjunct to oral rehydration therapy in children with diarrhea. J Pediatr Gastroenterol Nutr 2006;42(4):362–368.

    Article  PubMed  CAS  Google Scholar 

  20. Ramakrishna BS, Subramanian V, Mohan V, et al. A randomized controlled trial of glucose versus amylase resistant starch hypo-osmolar oral rehydration solution for adult acute dehydrating diarrhea. PLoS One 2008;3(2):e1587.

    Article  PubMed  Google Scholar 

  21. Qureshi K, Molbak K, Sandstrom A, et al. Breast milk reduces the risk of illness in children of mothers with cholera: observations from an epidemic of cholera in Guinea-Bissau. Pediatr Infect Dis J 2006;25(12):1163–1166.

    Article  PubMed  Google Scholar 

  22. Coppa GV, Zampini L, Galeazzi T, et al. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 2006;59(3):377–382.

    Article  PubMed  CAS  Google Scholar 

  23. Dalton CB, Austin CC, Sobel J, et al. An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N Engl J Med 1997;336(2):100–105.

    Article  PubMed  CAS  Google Scholar 

  24. Ooi ST, Lorber B. Gastroenteritis due to Listeria monocytogenes. Clin Infect Dis 2005;40(9):1327–1332.

    Article  PubMed  Google Scholar 

  25. Aureli P, Fiorucci GC, Caroli D, et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med 2000;342(17):1236–1241.

    Article  PubMed  CAS  Google Scholar 

  26. Beaugerie L, Petit JC. Microbial–gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004;18(2):337–352.

    Article  PubMed  CAS  Google Scholar 

  27. Gorkiewicz G. Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium difficile. Int J Antimicrob Agents 2009; 33(Suppl 1):S37–S41.

    Article  PubMed  CAS  Google Scholar 

  28. Jernigan J, Guerrant RL, Pearson RD. Parasitic infections of the small intestine. Gut 1994;35(3):289–293.

    Article  PubMed  CAS  Google Scholar 

  29. Haque R, Roy S, Kabir M, Stroup SE, Mondal D, Houpt ER. Giardia assemblage A infection and diarrhea in Bangladesh. J Infect Dis 2005;192(12):2171–2173.

    Article  PubMed  Google Scholar 

  30. Sahagun J, Clavel A, Goni P, et al. Correlation between the presence of symptoms and the Giardia duodenalis genotype. Eur J Clin Microbiol Infect Dis 2008;27(1):81–83.

    Article  PubMed  CAS  Google Scholar 

  31. Lebwohl B, Deckelbaum RJ, Green PH. Giardiasis. Gastrointest Endosc 2003;57(7):906–913.

    Article  PubMed  Google Scholar 

  32. Egyed Z, Sreter T, Szell Z, Varga I. Characterization of Cryptosporidium spp.—recent developments and future needs. Vet Parasitol 2003;111(2–3):103–114.

    Article  PubMed  CAS  Google Scholar 

  33. Rossignol JF. Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 2009.

    Google Scholar 

  34. Parasites of the Intestinal Tract (Accessed Aug 20, 2009, at http://www.dpd.cdc.gov/dpdx/).

  35. Alfredson DA, Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiol Lett 2007;277(2):123–132.

    Article  PubMed  CAS  Google Scholar 

  36. Nachamkin I, Ung H, Li M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982–2001. Emerg Infect Dis 2002; 8(12):1501–1503.

    Article  PubMed  Google Scholar 

  37. Su LH, Chiu CH. Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J 2007;30(3):210–219.

    PubMed  Google Scholar 

  38. WHO Global Salmonella Survey, 2000–2005. WHO Press, World Health Organization, 2006 (Accessed Sept 4, 2009, at http://www.who.int/salmsurv/links/GSSProgressReport2005.pdf).

  39. Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004;190(9):1652–1654.

    Article  PubMed  Google Scholar 

  40. Molbak K. Human health consequences of antimicrobial drug-resistant Salmonella and other foodborne pathogens. Clin Infect Dis 2005;41(11):1613–1620.

    Article  PubMed  Google Scholar 

  41. Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005;191(4):554–561.

    Article  PubMed  Google Scholar 

  42. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis 2004;39(4): 546–551.

    Article  PubMed  CAS  Google Scholar 

  43. Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increasing ceftriaxone resistance in Salmonella isolates from a university hospital in Taiwan. J Antimicrob Chemother 2005;55(6):846–852.

    Article  PubMed  CAS  Google Scholar 

  44. Niyogi SK. Shigellosis. J Microbiol 2005;43(2):133–143.

    PubMed  Google Scholar 

  45. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med 1997;126(9):697–703.

    PubMed  CAS  Google Scholar 

  46. Taylor DN, McKenzie R, Durbin A, et al. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge. Clin Infect Dis 2006;42(9):1283–1288.

    Article  PubMed  CAS  Google Scholar 

  47. Gyles CL. Shiga toxin-producing Escherichia coli: an overview. J Anim Sci 2007;85(13 Suppl):E45–E62.

    Article  PubMed  CAS  Google Scholar 

  48. Talan D, Moran GJ, Newdow M, et al. Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens. Clin Infect Dis 2001;32(4):573–580.

    Article  PubMed  CAS  Google Scholar 

  49. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005;365(9464):1073–1086.

    PubMed  CAS  Google Scholar 

  50. Iijima K, Kamioka I, Nozu K. Management of diarrhea-associated hemolytic uremic syndrome in children. Clin Exp Nephrol 2008;12(1):16–19.

    Article  PubMed  Google Scholar 

  51. Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001;33(7):923–931.

    Article  PubMed  CAS  Google Scholar 

  52. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic–uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000;342(26):1930–1936.

    Article  PubMed  CAS  Google Scholar 

  53. Ochoa TJ, Chen J, Walker CM, Gonzales E, Cleary TG. Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli. Antimicrob Agents Chemother 2007;51(8):2837–2841.

    Article  PubMed  CAS  Google Scholar 

  54. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353(23):2433–2441.

    Article  PubMed  CAS  Google Scholar 

  55. Sailhamer EA, Carson K, Chang Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009;144(5):433–439; discussion 9–40.

    Article  PubMed  Google Scholar 

  56. Lamontagne F, Labbe AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245(2):267–272.

    Article  PubMed  Google Scholar 

  57. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342(6):390–397.

    Article  PubMed  CAS  Google Scholar 

  58. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16(8):459–477.

    Article  PubMed  CAS  Google Scholar 

  59. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45(3):302–307.

    Article  PubMed  CAS  Google Scholar 

  60. Surawicz CM. Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2004;1(1):32–38.

    Article  PubMed  Google Scholar 

  61. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000;95(11):3283–3285.

    PubMed  CAS  Google Scholar 

  62. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003;36(5):580–585.

    Article  PubMed  Google Scholar 

  63. Leclercq A, Martin L, Vergnes ML, et al. Fatal Yersinia enterocolitica biotype 4 serovar O:3 sepsis after red blood cell transfusion. Transfusion 2005;45(5): 814–818.

    Article  PubMed  Google Scholar 

  64. Zheng H, Sun Y, Lin S, Mao Z, Jiang B. Yersinia enterocolitica infection in diarrheal patients. Eur J Clin Microbiol Infect Dis 2008;27(8):741–752.

    Article  PubMed  CAS  Google Scholar 

  65. Dechet AM, Yu PA, Koram N, Painter J. Nonfoodborne Vibrio infections: an important cause of morbidity and mortality in the United States, 1997–2006. Clin Infect Dis 2008;46(7):970–976.

    Article  PubMed  Google Scholar 

  66. Centers for Disease Control and Prevention (CDC). Vibrio illnesses after Hurricane Katrina—multiple states, August–September 2005. MMWR Morb Mortal Wkly Rep 2005;54(37):928–931.

    Google Scholar 

  67. Jung EY, Kim DW, Lee DW, Cho HS, Chang SH, Park DJ. Vibrio vulnificus peritonitis after eating raw sea fish in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). Nephrol Dial Transplant 2007;22(5):1487.

    Article  PubMed  Google Scholar 

  68. Lee JY, Park JS, Oh SH, Kim HR, Lee JN, Shin JH. Acute infectious peritonitis caused by Vibrio fluvialis. Diagn Microbiol Infect Dis 2008;62(2):216–218.

    Article  PubMed  Google Scholar 

  69. You IC, Ahn M, Yoon KW, Yoon KC. A case of Vibrio vulnificus keratitis. Jpn J Ophthalmol 2008;52(2):131–133.

    Article  PubMed  Google Scholar 

  70. Tsai YH, Huang TJ, Hsu RW, et al. Necrotizing soft-tissue infections and primary sepsis caused by Vibrio vulnificus and Vibrio cholerae non-O1. J Trauma 2009;66(3):899–905.

    Article  PubMed  Google Scholar 

  71. Kuo CH, Dai ZK, Wu JR, Hsieh TJ, Hung CH, Hsu JH. Septic arthritis as the initial manifestation of fatal Vibrio vulnificus septicemia in a patient with thalassemia and iron overload. Pediatr Blood Cancer 2009;53(6):1156–1158.

    Article  PubMed  Google Scholar 

  72. Li XC, Xiang ZY, Xu XM, Yan WH, Ma JM. Endophthalmitis caused by Vibrio alginolyticus. J Clin Microbiol 2009;47(10):3379–3381.

    Article  PubMed  Google Scholar 

  73. Lai CH, Hwang CK, Chin C, Lin HH, Wong WW, Liu CY. Severe watery diarrhoea and bacteraemia caused by Vibrio fluvialis. J Infect 2006;52(3):e95–e98.

    Article  PubMed  Google Scholar 

  74. Kain KC, Kelly MT. Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea. J Clin Microbiol 1989;27(5):998–1001.

    PubMed  CAS  Google Scholar 

  75. Khan AM, Faruque AS, Hossain MS, Sattar S, Fuchs GJ, Salam MA. Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study. J Trop Pediatr 2004;50(6):354–356.

    Article  PubMed  CAS  Google Scholar 

  76. Schlenker C, Surawicz CM. Emerging infections of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2009;23(1):89–99.

    Article  PubMed  Google Scholar 

  77. Woo PC, Lau SK, Yuen KY. Biliary tract disease as a risk factor for Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literature. N Microbiol 2005;28(1):45–55.

    Google Scholar 

  78. Misra SP, Misra V, Dwivedi M, Gupta SC. Colonic tuberculosis: clinical features, endoscopic appearance and management. J Gastroenterol Hepatol 1999;14(7):723–729.

    Article  PubMed  CAS  Google Scholar 

  79. Kochhar R, Rajwanshi A, Goenka MK, et al. Colonoscopic fine needle aspiration cytology in the diagnosis of ileocecal tuberculosis. Am J Gastroenterol 1991;86(1):102–104.

    PubMed  CAS  Google Scholar 

  80. Beaugerie L, Metz M, Barbut F, et al. Klebsiella oxytoca as an agent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol 2003;1(5):370–376.

    Article  PubMed  Google Scholar 

  81. Haque R, Huston CD, Hughes M, Houpt E, Petri WA Jr. Amebiasis. N Engl J Med 2003;348(16):1565–1573.

    Article  PubMed  Google Scholar 

  82. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007;37(1):11–20.

    Article  PubMed  CAS  Google Scholar 

  83. Pritt BS, Clark CG. Amebiasis. Mayo Clin Proc 2008;83(10):1154–1159; quiz 9–60.

    Article  PubMed  Google Scholar 

  84. Rossignol JF, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005;3(10):987–991.

    Article  PubMed  CAS  Google Scholar 

  85. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991;4 (Suppl 1):S29–S35.

    PubMed  Google Scholar 

  86. Whitley RJ, Jacobson MA, Friedberg DN, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society—USA. Arch Intern Med 1998;158(9):957–969.

    Article  PubMed  CAS  Google Scholar 

  87. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58(RR-4):1–207; quiz CE1–4.

    Google Scholar 

  88. McGee S, Abernethy WB 3rd, Simel DL. The rational clinical examination. Is this patient hypovolemic? JAMA 1999;281(11):1022–1029.

    Article  PubMed  CAS  Google Scholar 

  89. Gill CJ, Lau J, Gorbach SL, Hamer DH. Diagnostic accuracy of stool assays for inflammatory bacterial gastroenteritis in developed and resource-poor countries. Clin Infect Dis 2003;37(3):365–375.

    Article  PubMed  Google Scholar 

  90. Silletti RP, Lee G, Ailey E. Role of stool screening tests in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens. J Clin Microbiol 1996;34(5):1161–1165.

    PubMed  CAS  Google Scholar 

  91. WHO/UNICEF. Clinical management of acute diarrhoea. WHO/UNICEF Joint Statement 2004.

    Google Scholar 

  92. Gadewar S, Fasano A. Current concepts in the evaluation, diagnosis and management of acute infectious diarrhea. Curr Opin Pharmacol 2005;5(6):559–565.

    Article  PubMed  CAS  Google Scholar 

  93. Riddle MS, Arnold S, Tribble DR. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler’s diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008;47(8):1007–1014.

    Article  PubMed  CAS  Google Scholar 

  94. Surawicz CM. GI infections of the small intestine and colon. In: Chang E, ed. Digestive diseases, Self Education Program (DDSEP V and 2006). Bethesda, MD: AGA, 2004.

    Google Scholar 

Download references

Acknowledgments

Special thanks to John R. Newton, MD, for his support and assistance with research.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Washington, Seattle, WA, USA

    Jennifer M. Newton MD

  2. Department of Medicine, Harborview Medical Center, University of Washington, 325 9th Ave, Box 359773, 98104, Seattle, WA, USA

    Christina M. Surawicz MD, MACG

Authors
  1. Jennifer M. Newton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina M. Surawicz MD, MACG
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Celiac Disease Center, Div. Pediatric Gastroenterology,, University of Chicago, S. Maryland Ave. 5839, Chicago, 60637, Illinois, USA

    Stefano Guandalini

  2. Health Center, Div. Gastroenterology, University of Connecticut, Farmington Ave. 263, Farmington, 06030-1845, Connecticut, USA

    Haleh Vaziri

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Newton, J.M., Surawicz, C.M. (2010). Infectious Gastroenteritis and Colitis. In: Guandalini, S., Vaziri, H. (eds) Diarrhea. Clinical Gastroenterology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-183-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-183-7_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-182-0

  • Online ISBN: 978-1-60761-183-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation